¥¿Åé      Â²Åé

2023 ¦~ 1 ¤ë 27 ¤é  ­º ­¶

¥þ°ê°|©Ò

ÃÄ«~¬d¸ß

ºô¸ô±¾¸¹

¾ã«¬¬ü®e

°·±d³ø¾É

ÂåÀø·s»D

ºô¯¸½×¾Â

¸ê°T¥æ¬y

ºô¸ôATM

   ¯¸¤º¸ê®Æ®w

  

¡@

©µ¦ùÂsÄý

¡u°­ªùÃö«e¨«¤@¾D¡v

¬°Àù¤Í§ä±Ï©R·sÃÄ ½×

°O¾Ð¤O°I°h ­ì¨Ó¬O¥¨

¸£°Ê¯ß¦åºÞ½F¡uÃz¬µ¡v

¨C¶g³Ü¥N¿}¶¼ ¬ã¨s¡G

Àç¾i§¡¿Å¡B¥Î¤ß³­¦ñ

²ö¦WÀYµhÀY·w·Q¦R «æ

«æ©Ê¸£¤¤­·¥Î­°¦åÀ£ÃÄ

§õ±Î¦ÛÃn¥u³Ñ3¦~©R¡K

§õ±Î¿©±w¸£½F³Ñ3¦~¥Í

§õ±Î¦ÛÃz¿©±w¸£½F¥u³Ñ

§õ±Î¿©±w¸£½F Âå¡G¸ò

¡@

³Ì¦hÂsÄý

¡@

4C§Ö­×³sÂêªù¥«-¥x¥_ºû­×¹q¸£,¤T­«ºû­×¹q¸£,¥x¥_²Õ¸Ë¹q¸£,¤T­«²Õ¸Ë¹q¸£,ºû­×¹q¸£¥x¥_,ºû­×¹q¸£¤T­«,¥x¥_ºû­×¤â¾÷,¤T­«ºû­×¤â¾÷,ºû­×¤â¾÷¥x¥_,ºû­×¤â¾÷¤T­«,²Õ¸Ë¹q¸£¥x¥_,²Õ¸Ë¹q¸£¤T­«,¥x¥_ºû­×¥­ªO,¤T­«ºû­×¥­ªO,ºû­×¥­ªO¥x¥_,ºû­×¥­ªO¤T­«,¥x¥_ºû­×µ§¹q,¤T­«ºû­×µ§¹q,ºû­×µ§¹q¥x¥_,ºû­×µ§¹q¤T­«.

­×¤â¾÷/­×¹q¸£
­×µ§¹q/­×¥­ª©

  ¡iÃþ§O¡j¡GÂå¾Ç¯f²z ¡÷ ªc§¿*¯«¸g¬ì ¡÷ ¸£¬ì

½u¤W¿Ô¸ß

26540¤HÆ[¬Ý






¡@
¦^ ¸£¬ì

facebook  ¼P®ö Plurk  twitter  delicious  MyShare  Windows Live  yahoo  google  FunP ±À±À¤ý  

¡@
¸£°ÊÀR¯ß·î«¬
¡@

¸£°ÊÀR¯ß·î«¬(AVM)

¥Ò¡B ¯f¦]
„X¥ý¤Ñ©Ê¤§²§±`¦åºÞ©ó¸£¹ê½è¤º¡A¥i¯à¬O­F­L®É´Á´`Àôµo¨|²§±`¤Î«ùÁZµÛ­ì©lªºAV shunt¦ÓµL¬y¸g·L¦åºÞ¡A°Ê¯ßÀ£¤O¨ÏÀR¯ß¦åºÞÂX±i¡A±`¦ñÀHÂX±iªºfeeding arteryºÞ¾À·Á¦Ó¯Ê¤Ö¥¿±`ªº¦Ù¦×¼h¤Îelastica¤º¼h¡A¦åºÞ¹ï©ó¦åÀ£©M¦å¬y§ïÅܨS¦³¥¿±`ªºautoregulation¡C
¤A¡B ¯gª¬
1.¸£¤º¥X¦å¡ASAH©Î¸£«Ç¤º¥X¦å¡C(Hemorrhage¦û¤@¦ñ¡Apeak age¬°15-20y/o, mortality¬°10%¡Amorbidity¦û30-50%)¡AAVM¥X¦å¦û¥X¦å©Ê¤¤­·ªº2.5-4.8%¡C
2.Åöíw25-50%·|¥X²{§½³¡©Î¥þ¨­Åöíw¡C(·U¦~»´risk·U°ª)
3.ÀYµh(³Ì±`¨£)
4.§½³¡¯«¸g¯gª¬¡B¦pªÏÅé·Pı²§±`¡BµL¤O¡Bµø³¥¯Ê·lµ¥¡C
5.IICP
¤þ¡B ªvÀø
1.­Y¸£¤º¦å¶ô¤Ó¤j¡A¤w³y¦¨uncal herniation¡A¶·§@ºò«æ¤â³N¡C
2.ª`·N¥Í©Rªí¼x¡BGCS¡BÀû¤Õ¡BªÏÅé¤O¶q¤§ÅܤơA¨C¤G¤p®É°O¿ý¤@¦¸¡A±±¨î¦åÀ£¡C
3.4 Vessels cerebral angiography¡C
4.²`³¡¤§AVM©ÎSize¤p©ó3cm¥i¦Ò¼{¥ÎStereotactic Radiosurgery¡C
Top
ICH¸£¤º¥X¦å

¥Ò¡B¯f¦]
1.Hypertension
2.Acutely increased CBF
3.Vascular anomalies
4.Arteriopathy
5.Brain tumor
6.Coagulation disorder
7.Infection
8.Drug abuse
9.Post-traumatic
¤A¡B Common sites of ICH
„XBasal ganglia (50%), thalamus (15%), pons (10-15%), Cerebellar (10%), Cerebral white matter(10-20%)
¤þ¡BManagement
1.initial:
a.reduction of hypertension (HTN)¡A¦ý¤£¯àover reatment­°§CMAP¬°Admission MAP¤§80%
b.Anticonvulsant
c.Treat IICP: mannitol or Glycerol
d.Arrange angiography if atypical ICH: to R/O AVM, Aneurysm or tumor
2.Surgical indication
a.Symptomatic lesion
b.Lesions with marked mass effect, edema, midline shift
c.Persistent IICP
d.Favorable location: ¦plobar, cerebellar, extenal capsule, non-dominant hemisphere
e.¡Ø50y/o and tolerate surgery



¡°¤p¥mÀ{¡G§ë½Z©Î¤Þ­z¤å³¹¤º®e½Ð°O±oµù©ú¥X³B¡A¥H¥Ü´L­«¨äµÛ§@°]²£Åv§Q¡A­Õ¦³²¨º|¤§³B¤]Åwªï¨Ó«H«ü±Ð¡AÁÂÁ¡C

¡@

¡@

§ë½Z«H½c

¸É¥R·N¨£



¡@


[±ÀÂ˵û»ù¦n©±]- 4C§Ö­×³sÂêªù¥«
±M·~ºû­×¶R½æ - µ§¹q + ¤â¾÷ + ¹q¸£ + Iphone + Ipad

·s¥_¦Á¤î©±
(02) 7751-9182
·s¥_¥«¦Á¤î°ÏºÖ¼w¤@¸ô86«Ñ22¸¹
¦Á¤î­×¤â¾÷.¦Á¤î­×iphone.¦Á¤î­×ipad.¦Á¤î­×µ§¹q.¦Á¤î­×¹q¸£
·s¥_ªO¾ô©±
(02) 8257-3990
·s¥_¥«ªO¾ô°Ï¥|ºû¸ô137«Ñ10¸¹
ªO¾ô­×¤â¾÷.ªO¾ô­×iphone.ªO¾ô­×ipad.ªO¾ô­×µ§¹q.ªO¾ô­×¹q¸£
·s¥_άw©±
(02) 8285-7369
·s¥_¥«Äª¬w°Ï¤¤¤s¤G¸ô213¸¹
άw­×¤â¾÷.άw­×iphone.άw­×ipad.άw­×µ§¹q.άw­×¹q¸£
·s¥_¤T­«©±
(02) 2973-7288
·s¥_¥«¤T­«°Ï¤¤¥¿«n¸ô1¸¹
¤T­«­×¤â¾÷.¤T­«­×iphone.¤T­«­×ipad.¤T­«­×µ§¹q.¤T­«­×¹q¸£
®ç¶é¥«°Ï©±
(03) 387-4353
®ç¶é¥«®ç¶é°Ï¨|¼Öµó45¸¹
®ç¶é­×¤â¾÷.®ç¶é­×iphone.®ç¶é­×ipad.®ç¶é­×µ§¹q.®ç¶é­×¹q¸£
®ç¶é¤j·Ë©±
(03) 387-4353
®ç¶é¥«¤j·Ë°Ï¤¤µØ¸ô210¸¹
¤j·Ë­×¤â¾÷.¤j·Ë­×iphone.¤j·Ë­×ipad.¤j·Ë­×µ§¹q.¤j·Ë­×¹q¸£
·s¦Ë¦ËªF©±
(03) 545-6220
·s¦Ë¿¤¦ËªFÂíªø¬K¸ô¤G¬q65¸¹
¦ËªF­×¤â¾÷.¦ËªF­×iphone.¦ËªF­×ipad.¦ËªF­×µ§¹q.¦ËªF­×¹q¸£

¡@

¤ý®v¤÷±M·~Àð¾À¤Á¤ÕÆp¤Õ¤Þ¤Õ¤uµ{ªA°È
Àð¾ÀÆp¤Õ¤Á³Î,Àð­±¤Þ¤ÕÆp¤Õ,¦aªOÆp¤Õ¤Á³Î

¥x¥_Æp¤Õ¤Á³Î
¤T­«Æp¤Õ¤Á³Î
·s²øÆp¤Õ¤Á³Î
ªO¾ôÆp¤Õ¤Á³Î

¡@
¡@

     ³sµ²Àu¨}¸ê°T¤J¤fºô ¥»¯¸¤J³ò½Ã¥Í¸p95¦~«×Àu¨}°·±d¸ê°Tºô¯¸      ¥xÆWÂåÀøºô ª©Åv©Ò¦³
  © 2006-2022 TW16 Network! Taiwan Inc. All Rights Reserved.   
«ÈªA«H½c